Imperial Brands PLC (IMB) Earnings Call Transcript & Summary

November 14, 2023

London Stock Exchange GB Consumer Staples Tobacco earnings 63 min

Earnings Call Speaker Segments

Stefan Bomhard

executive
#1

Good morning, everyone here in the room — and a warm welcome from me to our fiscal 2023 results presentation. Thank you, particularly to those of you who have joined us in person in London, and I also want to greet everyone watching us online today. As always, I'll begin by pointing you to the disclaimer before introducing the rest of the team and the agenda. On the team — you'll all be familiar with Lukas Paravicini, our Chief Financial Officer, and I'm sure you know Peter Durman, our Head of Investor Relations. Yeah. What I'll do today is, first, highlight the key achievements from today's results. Lukas will then take you through our financial delivery for the year, and we'll also provide an outlook for the next 12 months. After that, I'll return to update you on the broader range and transformation of the company as we build a business that delivers sustainable growth. Finally, the two of us are very much looking forward to answering any questions you may have. Now, I'm pleased to report that these results offer further evidence of the strong progress we're making under our 5-year strategic plan.

Stefan Bomhard

executive
#2

Here are the main points, as you can see on this slide: First, the investments we're targeting are producing additional aggregate market share gains across our priority combustible markets. Second, we've achieved strong pricing and expanded margin even with high inflation and consumers whose wallets are squeezed. Third, in Next Generation Products, our challenger approach to innovation, together with disciplined execution, is speeding up revenue growth. And fourth, while we're once again delivering on our annual plans, we're also making very good progress on our long-term transformation. Now, as I'll go into in more detail later, we are patiently building a new culture, new capabilities, and new ways of working. And these results offer further evidence that we're becoming a more resilient business, delivering stronger returns to you, our shareholders. At the same time, we're also taking a more active role in the industry's transition towards a healthier, more sustainable business model. Now, we run this business using a balanced dashboard of operational and financial measures. For the third year in a row, this dashboard is a sea of green, with all arrows pointing in the right direction. The one that jumps out at me is obviously the 3.9% increase in profitability, demonstrating to you the acceleration in profit growth we promised you this year.

Stefan Bomhard

executive
#3

As you know, competition in our industry is intense, and our core product's volumes are declining, so achieving these results with this level of quality and consistency isn't easy. So at this moment, I'd like to express deep appreciation to our 25,000 colleagues around the globe, since each additional basis point of market share shown here, along with every GBP of extra revenue, stems from the company's strategic focus and our teams' hard work. Another thing that's gratifying about this dashboard is how it shows operational success in Combustibles and NGP feeding straight through into financial progress, and from there into rising capital returns for shareholders. Beyond the 10% uplift in our ongoing share buyback program that we announced last month, today we're announcing a 4% rise in the average interim. All of this is solid proof that our strategy is delivering. When I come back, I'll attempt to bring this strategy to life in somewhat more detail. But right now I wanted to pass things to Lukas, who'll walk you through the financial results. Over to you, Lukas.

Lukas Paravicini

executive
#4

Thanks a lot, Stefan. Good morning, everyone. We've had yet another year of robust financial performance. Having spent the first two years laying foundations, we're now witnessing our returns speed up. Against the key financial metrics, the business came in right where we expected. On a like-for-like basis, net revenue from Tobacco and NGP rose 1.4%, powered by share gains across the board and solid pricing. Within NGP, fresh products plus targeted market launches contributed to quicker net revenue growth, especially across Europe. Consistent with our strategy, we achieved faster growth in adjusted operating profit, and that underpinned EPS growth. Thanks to this robust performance, we're once again able to satisfy our capital allocation priorities. Leverage stood at 1.9x, and we expect to keep it near 2x. Our cash position is still solid, with GBP 2.4 billion in free cash flow. We gave back roughly GBP 2.3 billion to you in the past year, through ordinary dividends plus the GBP 1 billion share buyback. We stay dedicated to our multi-year capital returns program, and our GBP 1.1 billion buyback for the coming year is well underway. Tobacco volume, price, and mix look much as they did at the half year. Solid pricing gains, shown here in orange, have kept on offsetting the volume headlines, shown here in blue.

Lukas Paravicini

executive
#5

Starting on the left with the U.S.: pricing was up 10%, and that came from our cigarettes portfolio. On volume, you need to separate our cigarette portfolio from our mass-market cigars. Cigarette volumes held up well — they were down only 2%, while the industry saw declines of more than 8%.

Operator

operator
#6

Could I get everyone’s attention, please? Everyone, your attention, please. A fire has been reported inside the building. Kindly exit the building right away using the closest exit. Please do not use the lifts. Please take the closest stairway.

Lukas Paravicini

executive
#7

A lot of things happened to me before, though not this one.

Operator

operator
#8

Could I get everyone’s attention, please? Everyone, your attention, please. There’s been a report of a fire in the building. Please exit the building right away—

Peter Durman

executive
#9

Hi. Thanks for bearing with us. We’re going to begin the presentation again now. We’ll pick it up right at the start of Lukas’s section. So please stay with us while we do that, and after that we’ll go through everything and, as always, take your Qs and As. Thanks a lot. Cheers. Over to you.

Stefan Bomhard

executive
#10

We appreciate you staying with us.

Peter Durman

executive
#11

Right.

Stefan Bomhard

executive
#12

You know, this one is going to stick with you. Go ahead and buy it.

Peter Durman

executive
#13

That is correct. Precisely.

Lukas Paravicini

executive
#14

You’ll hear it two times.

Peter Durman

executive
#15

Right, exactly. That's great. Thank you, Lukas.

Lukas Paravicini

executive
#16

Are we all set to begin?

Stefan Bomhard

executive
#17

Yeah.

Lukas Paravicini

executive
#18

Morning, everyone, and thanks for joining us again. We’ve had another solid year in financial terms. Having spent the first two years building the foundation, we’re now seeing our returns speed up. The business performed as we expected and against the key financial measures. Net revenue from tobacco and NGP rose 1.4% on a like-for-like basis, helped by share gains across a broad front and firm pricing. Within NGP, new products and focused market launches contributed to quicker net revenue growth, especially in Europe. Consistent with our strategy, we achieved faster growth in adjusted operating profit, which in turn supported EPS growth. Given this robust performance, we can once again satisfy our capital allocation priorities. Leverage stood at 1.9x, and we expect to keep it at about 2x. Cash generation stayed robust, with GBP 2.4 billion of free cash flow, and we returned roughly GBP 2.3 billion to you last year through ordinary dividends plus the 1 billion share buyback. We stay dedicated to our multi-year capital returns program, and our GBP 1.1 billion share buyback for next year is progressing well. Tobacco volume, price, and mix look much as they did at the half year. Solid pricing gains—shown here in orange—have kept offsetting volume headwinds, which appear here in blue.

Lukas Paravicini

executive
#19

Starting on the left side with the Americas, in the U.S., pricing rose 10%, and that came from our cigarette portfolio. On volumes, it matters to separate our cigarette portfolio from our mass market cigars. Cigarette volumes performed solidly, down only 2%, while industry declines were over 8%. Yet, as in the first half, cigars make up most of the 6% drop in total U.S. volumes. Hurricane Ian in September last year caused wholesaler inventory movements that have weighed on our cigar performance. We are also observing a rebalancing of market size and share post-COVID. That cigar volume decline likewise produced most of the negative mix of 9%. The reason is that our cigars are comparatively high value and low volume products, with net revenue per stick 2.5x that of a cigarette. As a result, any shift in our cigar business, whether up or down, has an outsized effect on overall product mix. Shortly, Stefan will say more about the dynamics of our U.S. business and the positive outlook for our cigars. Turning to Europe and AAA, pricing was exceptionally strong at 11%, which more than offset volume declines, yielding strong revenues and a better gross margin.

Lukas Paravicini

executive
#20

Looking at the group overall, leaving out Russia, volumes fell 7% versus a tough comparator, with a decline of only 1.2%. Now on operating profit, again excluding Russia, adjusted operating profit rose 3.9% on a constant currency basis. You can see here that better performance in tobacco and at Logista largely drove this growth. As I mentioned, strong pricing helped profitability in tobacco, and we lifted operating margins by 150 basis points. Consistent with our plan to put money into new products at markets, NGP losses went up by GBP 42 million, and we're still on track to break even by the close of our five-year plan. Logista's positive contribution came from robust underlying performance, aided by pricing and targeted acquisition. That M&A was a significant step in Logista's diversification strategy, which we back. It also means tobacco now accounts for under half of their sales. As with other businesses, we make certain adjustments to our IFRS numbers to help compare performance over time. When I joined Imperial, I committed to being transparent with you about these adjustments, and I'll keep doing that. The first item, of GBP 4 million, came from a write-down of assets in Ukraine and our exit from certain Central Asian markets after our exit from Russia.

Lukas Paravicini

executive
#21

Number two is the standard amortization of acquired intangibles, which is very much consistent with last year. Number three is the fair value adjustment to financial assets, and that includes the group's investment in cannabis. We incurred GBP 85 million of charges relating to provisions for some legacy legal disputes, and those are all one-offs. Finally, I want to highlight that there were no adjustments for restructuring costs. On the contrary, our adjusted numbers absorbed some GBP 30 million of factory closure costs, which we have funded by the profit on sales of some former sites. That is a pragmatic approach to optimizing our factories. Turning to EPS. Our EPS benefited from improved profit growth and the share buyback. Of course, the averaging effect of the share buyback through the year contributed only 2.6%, and this will be compounded into next year. These benefits, as we said at half year, have been partially offset by higher interest, minorities, and tax costs. Interest costs have increased with higher interest rates and new bonds. However, we've mitigated the impact of rising interest by fixing around 85% of our debt. Looking ahead, we expect interest costs to increase this year to around GBP 460 million. Our adjusted effective tax rate is the same as last year.

Lukas Paravicini

executive
#22

But for the coming year, we anticipate a rate of roughly 23%. A core element of our strategy is generating cash strongly and allocating capital with discipline. Operational cash conversion—the conversion for the period—came in at 92%, compared with a strong comparator of 102%, which had benefited from the timing of duty payments at Logista. The business keeps producing substantial free cash flow to support our four capital allocation priorities. Investing in the business is our first priority, and this year we put money into organic growth and target acquisitions in NGP and Logista. Second, it concerns maintaining a strong and efficient balance sheet. Our year-end leverage came in marginally below our 2x target, aided by FX. We are recommending annual dividend growth of 4%, in line with our progressive dividend policy. Finally, we are continuing our multi-year share buyback program, raising it by 10% to GBP 1.1 billion for this coming year. That currently equates to 37% of share capital. We will keep managing these priorities responsibly, to deliver growing returns, while retaining some headroom for uncertainties. This was the first in the next phase of our strategy, and we have delivered the acceleration in profit growth that we promised.

Lukas Paravicini

executive
#23

Looking ahead to the next year, net revenue growth should come in at low single digits, and we anticipate additional profit growth improvement, with growth near the middle of our mid-single-digit range. The drivers behind this are pricing and operational gearing, a reduction in our NGP losses, a better geographic mix stemming from our focus on priority markets, and savings on costs. Because of how our prior-year pricing phased and NGP investments being front-loaded into the first half, performance will be weighted toward the second half. Consequently, first-half adjusted operating profit is projected at low single digits. At present, foreign exchange translation represents a 0%-1% headwind to the P&L. EPS will be driven by our improving profit growth along with the full year effect of the share buyback. More guidance, as usual, sits in the appendices. Even with macroeconomic and geopolitical challenges still present, the business has been strengthened by our strategy and investment, and that underpins our confidence for the year ahead. We are very well placed to create long-term value for our shareholders. Thank you very much — I'll now hand back to Stefan.

Stefan Bomhard

executive
#24

Thank you, Lukas. And now, on a personal note, thank you. It's hard to believe that this marks the fourth set of Imperial full year results I've had the chance to present to you, and each time it's a moment for reflection. So, going back to November 2020, our meetings could only happen virtually. The new executive team was only just coming together, and frankly, we were still looking into the business opportunities and weighing up our options. Come November 2021, we had planted those first acorns. The basic framework that you can see on the screen here now — our strategy, our purpose, and our behaviors — had been established at that point. Our teams had by then been mobilized around the distinctive vision that brought all these priorities together. We believed the time was right for a strong challenger business in our sector, and we thought that strong challenger ought to be us. At this point last year, we were reporting the first green shoots. We were seeing encouraging signs of stability in our core combustible business after many years, during which we have been the industry's number one share donor. We had started to reboot NGP, and there was positive feedback coming from our pilot markets. Now, today, we can say that our tree has grown its first branches and its first leaves.

Stefan Bomhard

executive
#25

When it comes to Combustibles, we’ve now got a 3-year record of stable share and robust pricing. In NGP, we have credible offerings across every key category, and there’s been a step change in financial performance as well as a step change in capital returns to you as shareholders. Now, although that growth is encouraging, we recognize we remain a long way from being a fully grown, mighty oak, and that is exactly what makes this moment so exciting for us at Imperial. We’ve achieved great progress so far, yet we can plainly see the upsides still ahead, and we know we can reach them provided we remain focused on the plan we have and we stick to that plan. Now, when I look at the chart I’ve shown you many times before, what excites me is how well it has aged. Sure, some things have occurred over the last 3 years that we did not fully anticipate. I mean, for instance, I think everyone here would have been surprised by the dynamism in the vaping market with the sudden emergence of disposables. But overall, what we’ve been doing is systematically working through the detailed plans that support each of the 6 segments in our strategy wheel: the 3 enablers and the 3 priorities.

Stefan Bomhard

executive
#26

Those five behaviors at the bottom of the chart—we've been weaving them in in a very structured manner as well. As we move our NGP business forward along with broader ESG priorities, progress is being made toward the healthier future that sits at the core of our company's purpose. Now, with our transformation moving ahead, we can finally show you the teams' hard work, along with some numbers that are just as hard. Back in June, at our New York event, we laid out for you how we committed to putting the consumer at the center of the business. On insights, we haven't only raised quality—through the demand spaces work we showed you earlier, for instance—we've raised quantity too. In the last year, for instance, our consumer tracker has grown to 120,000 participants across 35 countries, which is a 20% increase over last year. Our distinctive partnership approach to innovation is scaling as well, with three new hubs now open in Liverpool, Hamburg, and Shenzhen, and that is translating into a step change in how fast new products launch. The new performance culture we're investing in is also producing clear, measurable returns. During the last year, 300 leaders completed an intensive course running seven working days, built to sharpen their management and coaching skills.

Stefan Bomhard

executive
#27

Initiatives of that kind have helped lift engagement scores by 10.8 points among cohorts of global business leaders. Across the whole company, among all employees, we've held an engagement score of 74% that beats the benchmark, and our participation rate has come in above 90%, with 50,000 verbatim comments received via the survey. To give you a sense of scale, that works out to over two verbatims for each person who responded. While there is always space to do better, this is an encouraging indicator that we're carrying our people along with us on the transformation journey, and we keep working through the legacy of this company's acquisitive history, building simpler and more efficient ways of working and investing in data and our systems. The savings we promised at the launch of our strategy in 2021 have been delivered... yet it matters to note that the complete upside potential from our major investments in our single ERP platform, which we've discussed previously, will need time before it emerges. That future benefit is among the reasons why, just as we're pleased with what's been achieved over the past three years, we're equally enthusiastic about the prospects for additional progress in the years ahead. Turning to ESG, as part of our broader business strategy, we laid out some ambitious long-term objectives spanning eight priorities, and we're now delivering material progress toward those objectives through reductions in carbon emissions, waste, and lost time accidents.

Stefan Bomhard

executive
#28

We’re backing the delivery of those outcomes with a more structured way of governing ESG. There’s a cross-functional ESG committee that I chair, and it brings in every member of the executive leadership team. That gives us oversight and direction for our ESG agenda, and it’s what supports an approach that is more rigorous and more focused on performance. I’m looking forward to updating you on our progress at upcoming meetings. Let me now move to how we’re delivering against our three strategic priorities, beginning with the emphasis on our top five combustible markets. As I mentioned before, this marks the third consecutive year in which we’ve reported weighted market share that is stable or growing. At the same time, as we’ve discussed, we’ve kept strong discipline on pricing. Keep in mind that our medium-term objective is stable share at a portfolio level, so we don’t expect to grow share across all five markets in any given year. This year, we grew share in three of the top five markets: US, Spain, and Australia, while we lost share in U.K. and Germany. For fiscal year 2024, our planning assumption is that we will hold our full year share flat on last year. Now let me give you a deeper dive on our priority markets, starting with our largest, the U.S.

Stefan Bomhard

executive
#29

Like Lukas said, cigarettes had a strong year, though cigar challenges offset that. Our cigarette market share rose 65 basis points, and revenue growth was solid too. Once again we held or gained share across all three price segments we focus on, and pricing was strong and broad-based. Thanks to brand investments and retail initiatives for Winston and Kool, we maintained share in the premium value segment, which is highly competitive. With Maverick performing well, we also grew share in the traditional discount segment, and in the fast-growing deep discount price segment we picked up additional share, where Sonoma and Crowns kept growing volume and revenue. All of this came despite a challenging market dynamic, with market volumes down more than 8% year-on-year. In cigars, we've had a transition year. Still, the outlook is more positive now, and the three factors that hurt our performance in fiscal year 2023 are largely behind us at this point. First, and most significantly, we've normalized the wholesaler inventory changes that Hurricane Ian caused in September last year. Second, the wider COVID unwind affected us, and that has now annualized. Third, we lost share as competitors worked through earlier supply chain issues from COVID, and we also felt some pressure from consumers down trading.

Stefan Bomhard

executive
#30

Additionally, share trends have gotten better during the second half, helped by certain innovations we've implemented. Moving forward, cigar brands of ours such as Backwoods remain very well positioned in a category possessing appealing long-term traits. Now, across the remaining four priority markets, we've made certain quite deliberate decisions regarding balancing market share against delivering pricing and value. In the U.K., we raised prices near the start of the fiscal year. We expected a near-term hit to share, yet it was the correct call for creating value over the long term. During the year's second half, our share leveled out, thanks to the focus with which we ran our Local Jewels portfolio. We finished the year with growth in both revenue and profit in the U.K. Now, that was a great accomplishment, considering the steep contraction in market size, driven, A, by the COVID Unwind, and B, by the excise increase tied to high inflation. As you know, the U.K. Prime Minister recently announced an intention to bring in a generational ban on tobacco. A consultation process is underway, so certain details remain unclear. However, the soonest this regulation would take effect is in January 2027.

Stefan Bomhard

executive
#31

Turning now to Spain: for a second consecutive year we implemented price increases, following an extended stretch in which prices held steady. Simultaneously, we captured additional share, once more fueled by initiatives behind our Local Jewels brand. The relaunch of the Noble brand in 2022 has driven this, featuring fresh packaging and line extensions that have connected strongly with consumers in Spain. In Australia, refreshing our portfolio along with our pricing strategy — a sound pricing strategy — let us expand both share and value. In Germany, following share losses spanning more than a decade, we recorded an additional decline across the year. Even so, we are patiently putting investment into building brand equity and sales force effectiveness. That said, as we have noted previously, stabilizing market share in Germany will require some time on our part. Much as we concentrate investment in our five priority markets, we take an equally disciplined approach across our wider market portfolio. Accordingly, we established ways of working that assist teams in every market in maximizing what they contribute by pooling insights, expertise, and services. We are now applying the same principles we rely on in our five priority markets. Thus, go-to-market strategies and are successfully rolled out elsewhere in the group, and we have replicated them across a broader market portfolio.

Stefan Bomhard

executive
#32

Stronger engagement from consumers and customers has shaped where we put our money — brand innovations and the price increases that back them up. Our African cluster, which makes up 8% of operating profit — there, sizable price hikes were paired with Revenue Growth Management actions and additional tools we built together with our global consumer office team. Through our distinctive mix of Local Jewels and international brands, we've addressed what local consumers want. And take the Middle East, for example: international brands such as Davidoff connect really well with consumers, especially in Kuwait. That sharpened focus and discipline, paired with our fresh consumer capabilities, lets us keep extracting value from our wider market portfolio. Moving to NGP, I'd like to begin with a look at where we stand and what comes next. Across three years, this business was rebuilt nearly from nothing. First came a reset of our investment priorities, leaving certain markets like Heated Tobacco in Japan. Next we adopted a consumer-led test-and-learn method to figure out the best way to position our products and brands. That consumer evaluation mattered greatly before we put money into rolling out to more markets. Meanwhile, our fresh partnership-based approach to innovation produced a full refresh of what we offer across the three main NGP categories: vaping, Heated Tobacco, and modern oral.

Stefan Bomhard

executive
#33

So because of that, we've got new offerings across every one of those categories now, and they're credible. Naturally, we're not perfect anywhere. In most of the markets where we believe we've earned the right to win, we're already up and running. Over the coming 12 to 24 months, we'll go through a phase of consolidation — building scale in the existing markets that matter, along with some additional innovation and targeted market launches. My expectation is that the regulatory environment for innovation will stay highly dynamic. We'll keep fine-tuning what we offer. On top of that, it's still early days, and we remain very much in a position of coming from behind. You can see that all of these efforts are beginning to show up as an acceleration in revenue growth within NGP. Our approach to entering markets is that of a disciplined challenger. We've only launched products in markets where the category accounts for a big proportion of overall nicotine consumption and where we already have a strong route to market. As the chart shows, in certain markets NGP is on its way to overtaking Combustibles as the biggest source of revenue. Going forward, the major challenge and the major opportunity lie in replicating this relative success in markets such as Italy, Greece, and Austria, and in our large European markets like the U.K., Spain, and France.

Stefan Bomhard

executive
#34

So the three markets I mentioned a moment ago are all expanding in vaping, and within that segment we're currently operating across 11 European countries in total — quite a shift versus where we stood 12 months back. Our product range has been refreshed, featuring blu bar disposables along with the blu 2.0 pod system, and we anticipate further innovation over the next year. As you'll be aware, several European governments are drafting fresh regulations aimed at reducing usage and access while pushing out bad actors who sell illicit goods. We back these new rules, as long as they prove effective and proportionate, and we're working closely with the policymakers. Turning to Heated Tobacco, feedback from consumers shaped the creation and release of Pulze 2.0, our latest device. Thanks to an all-in-one form factor and 25 or more sessions per charge, it appeals to consumers who value the convenience of skipping recharges. Following 5 new market launches, the Pulze offering, together with our iD sticks, can now be found in seven European markets. That puts us in more than 60% of the addressable market across Europe. These are still early days, though, and we take nothing for granted.

Stefan Bomhard

executive
#35

Of course, rivals are coming up with fresh offerings of their own. Yet as we keep pushing product innovation that comes from within, this month we introduced iSenzia, a new line of tea-based nicotine sticks that contain no tobacco, available in a range of flavors. These are going to be introduced across our Heated Tobacco markets over the course of fiscal year 2024 as we keep updating our overall lineup. In modern oral nicotine, we achieved an acceleration in net revenue growth by launching new flavors, backed by stronger brand positioning. Zone X's footprint centers on the Nordics and other European markets that have a Snus tobacco heritage. There, we're crafting a distinctive offering with inventive flavors meant to draw in and keep adult consumers who are moving away from traditional Snus and other tobacco products. Thanks to our agile challenger approach, we became the first company to enter Finland after the government decided to permit modern oral products. Over the year, we kept delivering very strong results in modern oral across the Nordics, particularly Norway, driven by expansion of the Skruf Super White format, and in the key Norwegian market we are the fastest-growing modern oral player. In 2024, we will move into the biggest modern oral market in the world by launching a new U.S.

Stefan Bomhard

executive
#36

with the brand, through the selection of pouches that we bought earlier in the year. For our new strategy, the past year has provided the first major test. We encountered elevated inflation along with pressure on consumers' wallets. Inside the company, the rapid speed of our transformation carried on, and throughout all of that, we achieved share growth, robust pricing, and faster NGP expansion. We achieved an improvement in both financial results and returns to shareholders. Going forward, there will undoubtedly be additional challenges. The macroeconomic picture is plainly uncertain. The regulatory landscape is going to be active, and we hold a healthy regard for our rivals and their capacity to innovate themselves. We are establishing a history of results that gives us greater confidence that we are today a business that is more resilient and more agile than in earlier times. When we examine our pipeline of transformation initiatives, additional upside remains ahead. That future upside represents a key element of our investment case. We are creating a stronger tobacco business, alongside a sustainable NGP business that is growing, and we are taking on further self-help opportunities via new methods of working and by changing our culture. Every one of these underpins our medium-term financial delivery and our rising shareholder returns, with a 4% increase announced...

Stefan Bomhard

executive
#37

With the dividend we announced today and the 10% increase to our share buyback from last month, those two together come to roughly 15% of our present valuation. And we're only midway through the transformation, with further steps still ahead. So, in closing, Imperial offers a highly compelling chance to put money into a global consumer goods company that is dedicated to creating change by paving the way toward a healthier future. Thanks to everyone for joining us today, and Lukas and I would be very happy to field any questions from you, whether you're here in the room or joining online.

Peter Durman

executive
#38

Thanks. I appreciate that, Stefan. Now I’ll walk everyone through how the Q&A will work. Questions will be taken from those in the room first, and after that we’ll open it up to people who are with us on the phone. If you’d like to ask something remotely, you’ll need to sign up so you can get the dial-in information. You can find the registration link on the webcast page. In the upper right-hand corner, it’s labeled Phone Details, and that same information appears in today’s press release too. To ask a question by phone, just press star and 1 1 on your keypad. All right. If that’s fine, we’ll start with the first question from the room. Please wait for the microphone, and give your name and organization before you ask your question. So, is there anyone here in the room who’d like to ask something? Let’s begin—right there at the back, Jon.

Jon Lancaster

analyst
#39

Hi, this is Jon Lancaster from Société Générale. I have a couple of questions, please. The first one is obviously about price mix — you mentioned a fairly significant decline in price mix, or mix, I should say. Some of that is obviously mass market cigars. But on the FMC side, do you think that will continue to get worse, particularly as the majors are now starting to promote a lot more? And do you think the rest of the world is going to see a sort of mixed decline that offsets pricing? And secondly, on the expansion, or on getting NGP to sort of break even, I mean, what sort of — if that — does that. You seem to imply there aren't going to be many, too many market launches. What sort of sales growth are you expecting to actually get that business to sort of break even in a couple of years' time?

Stefan Bomhard

executive
#40

Sure. Thanks, Jon, for those two questions. Lukas is going to take the first one, and I'll handle the second.

Lukas Paravicini

executive
#41

Turning to your price mix question, I want to be quite clear: we enjoyed a very strong year for pricing within a very large context, and that in fact also drove gross margin higher. The mix effect, though, is really confined to the U.S. As you can see elsewhere in the world, there is barely any mix, and going forward we don't anticipate that changing. In the U.S., as you correctly noted, Jon, two effects are at play: the FMC and the MMC. It's quite evident that with the FMC we actually outperformed the market, and that matters a great deal. Our volumes fell far less than the market average. Our pricing was very strong, and the mix you observe there is really the deep discount volume that has grown while our Kool and Winston brands stayed at the same level. So that did not come at their expense, you know. That was the mix effect in that case. And we have, you know, a great deal of confidence for the coming year when it comes to FMC. MMC was a transition year. Stefan noted that it involved destocking, the post-COVID effect, the rebalancing of volumes, if you look back a few years.

Lukas Paravicini

executive
#42

So this really is a genuine rebalancing, and we will see those headwinds ease in 2024. All right, so that covers the U.S., and as I pointed out to you earlier, there really is no mix effect on the rest of the world.

Stefan Bomhard

executive
#43

Jon, turning to your second question, on NGP, what I find genuinely exciting—and I think the fiscal year 2023 results show this—is that our performance has really ramped up. Growth of 27% globally, with Europe, our focus region, up 40%, ought to give you confidence that we're now a serious player in NGP. Looking ahead, what remains unchanged is that commitment we made 3 years ago: this business will reach break-even at the close of fiscal year 2025, which is 2 years from today. One thing that matters, as you noted, concerns what we see for fiscal year 2024. In fiscal year 2023, we entered quite a number of markets in the NGP category. Going forward, we will enter the oral nicotine market in the U.S., a very significant investment for the company. Yet at the same time, we wanted to signal to you that we now have the right portfolio of markets with our NGP portfolio, so the focus will be on building out our position set. And at the same time, I think, when you consider the comment I made earlier regarding disposables, the NGP market remains a highly dynamic one.

Stefan Bomhard

executive
#44

That's the reason I hesitate somewhat to state which markets we'll enter or skip, or where we'll expand, since forecasting which ones will look most appealing in two years' time strikes me as hard. What I think you ought to take from this is that we are genuinely now competing, present in the markets that count, bringing a challenger mentality, with a business that truly is on course to deliver what we pledged three years back.

Peter Durman

executive
#45

We’ll take a question from Rashad. Thank you.

Rashad Kawan

analyst
#46

Hi folks, thanks so much. This is Rashad Kawan at Morgan Stanley. I have a couple of questions. First, regarding the U.S., you've shown impressive share gains once again this year, but looking ahead to next year, what makes you confident that you can keep the share gains you've achieved, assuming conditions there normalize, with inflation easing somewhat and consumption patterns possibly returning to more typical levels? Then for my second question, broadly on your revenue growth for next year, given the strong pricing we've seen this year, do you expect the mix to shift somewhat, with a bit less coming from pricing and somewhat fewer volume headwinds? Is that roughly the right way to frame it?

Stefan Bomhard

executive
#47

Yeah. Thanks for the question. I mean, no one can ever promise you what market share will look like a year from now, but I think what you should take from today's presentation is very clear, as we said in the presentation, we're either gaining share or holding share in every single segment. Yeah. And I think as we enter the US, I feel very strongly about the prospect of our US FMC business specifically, because we have better offers in every single place in the marketplace versus where we were three years ago, which reflects a massive investment we've done in sales force capabilities and coverage that will also help benefit us in fiscal year 2024. We also invested very significantly in the brand equities of our brands. Yeah? So as. I think we're very well prepared, whatever direction the U.S. consumer will take in fiscal year 2024 to have an Imperial offer for them.

Peter Durman

executive
#48

Great. Any further questions from the room?

Lukas Paravicini

executive
#49

Morning, everyone.

Stefan Bomhard

executive
#50

Yeah. Yeah. For sure. Now, commenting on pricing is always tough. I think the reality is, look, here we are. This is a marketplace that's highly competitive. We've now shown for three years in a row that we strike the right balance between volume and pricing. You can see that reflected in how our market share has developed within our top five. So going forward, we'll manage that mix the right way. So we'll watch what happens in the marketplace, but you're quite right to note that less pricing overall would probably deliver better volume performance for the market. But hopefully what you take away is that we now have the skill set, not only in the U.S. but around the world, to manage that the right way.

Peter Durman

executive
#51

Great. I think we'll hold off on questions from the room for a moment, if that's alright, since we do have a few questions coming in online. So I'll just pass things over to Sharon, the operator, to begin taking questions from the phone line.

Operator

operator
#52

Thanks. We’ll take the first call question now. Just a moment, please. The first call question is from Gaurav Jain at Barclays. Please go ahead.

Gaurav Jain

analyst
#53

Good morning. I have three questions. First, Stefan, looking at Imperial over recent years and your guidance for next year of 4.5 to 5% EBIT growth — Imperial hasn't achieved that in years. And considering the market mix: U.S. cigarette volumes overall are down 9%, the U.K. market is down mid-teens, Australia is down mid-teens, and Germany is better but you're losing share. Given that backdrop, what gives us confidence that your EBIT growth will accelerate next year?

Stefan Bomhard

executive
#54

Of course. Yes, absolutely. Gaurav, regarding this question, I mean, one thing that's important for us to remember is that in this fiscal year 2023, the year we just completed, there were some very significant headwinds when it came to the volume outlook. I mean, we refer to it as 7%, 7.1%. What we shouldn't forget is that the year before, the volume decline was 1.2%. So if you add the two years together, you're looking at a roughly 4.1% decline. That's very similar to what we had in the years pre-COVID, which was funny enough at 4%. Yeah? So I think what is, as some of the headwinds, specifically of the COVID unwind in some important markets like the UK, are coming behind us, we are forecasting, from what we can see, a slightly better volume performance. But I think what's also very clear, with very strong operational plans across all our top markets, that will allow us to deliver the performance that we kind of promised with our guidance today. So I feel very confident in our delivery in the year, and you've seen about a lot of the operational levers that we are pulling at this point in time. And I think I come back to the point, the question asked before, about one of the benefits we have as Imperial is that we have a brand at every single price point in the marketplace, in every one of our top five markets.

Stefan Bomhard

executive
#55

As a result, we can now serve our customers at every price point, and I believe that in today's environment that represents a distinct competitive advantage.

Lukas Paravicini

executive
#56

Let me just make one more point, if I can. You brought up a few markets — the U.K. and Australia in particular — where volume declines were steeper, and for very sound reasons: the COVID unwind and larger inflationary excise increases. Yet even in both of those places, we still grew revenue and profit despite those bigger volume drops. So hopefully that gives you some confidence too about the kind of value focus we bring to generating value from this portfolio, even in some of those tougher markets.

Gaurav Jain

analyst
#57

Alright. My second question concerns the ban on flavored Heated Tobacco that took effect in Europe last month, or three weeks ago. And what impact, if any, have you observed on your flavored Heated Tobacco products?

Stefan Bomhard

executive
#58

Absolutely, Gaurav. One thing that's completely correct: the European directive stated that as of last month, flavored Heated Tobacco sticks must be removed, yet that directive needs translation into individual local state laws. What you'll therefore observe is a genuinely staggered rollout extending from last month to a year from now. So it's too— I mean, the sole actual market where it has been withdrawn is the Czech Republic, which implemented early. That's where we've launched iSenzia, the product I mentioned earlier, a tea-based product. So as of today, it's much too soon to gauge what impact it has, but here's what I think you should take away, and I think the team feels quite good about this: we have turned into the challenger. Essentially on the very day the flavor ban hit the Czech Republic, Imperial gave its Pulze users in the marketplace a product that in fact let them keep enjoying the product the right way. Yeah. So too early to say, but I think the thrilling part is that we do have something on offer for our consumers within the Pulze system.

Gaurav Jain

analyst
#59

Okay, I just want to make sure — so the ban has taken effect only in the Czech Republic, and across the rest of the E.U., it's going to come in over the next few months?

Stefan Bomhard

executive
#60

Right. For sure. It varies from one country to the next, based on how each individual country converts that EU directive into its own local law.

Gaurav Jain

analyst
#61

Sure. For my final question, I want to ask about NGPs. You've mentioned that those losses are going to come off, and you've also said there will be a U.S. modern oral launch next year. Now, when some of your bigger competitors brought out a rival brand to Zyn, they spent — you know — a few tens of millions, maybe even hundreds of millions of dollars, just on discounting and securing shelf space in order to get into the market. How should we think about the possible investments behind Zone as you build that out in the U.S.?

Stefan Bomhard

executive
#62

Sure. Just to be clear, as you rightly point out, we devoted over a year to examining that US market, and in the spirit of a challenger company, we asked ourselves how we could deliver a differentiated offer to our consumers. Now, we can't discuss the product specifically — what it looks like, the branding and so on — but the reality is, we're quite confident that what we'll bring to the marketplace is a differentiated product and a differentiated brand. Yeah. And we view fiscal year 2024, and this falls within the financial guidance, as the investment year for getting the brand on the ground with US consumers. We're in the process of presenting our proposal to our US customers, our retail partners. They're quite excited about what we have to show them. More to follow on this one, but see it as a sign of confidence that we're now entering this important market with something that we believe brings something new to U.S. consumers.

Lukas Paravicini

executive
#63

Stefan, that's worth mentioning, I think — whatever investment we look at, and it'll very much follow the challenger approach we've taken before, sits inside the guidance we've provided. So all of that is accounted for in that guidance.

Gaurav Jain

analyst
#64

I really appreciate it.

Operator

operator
#65

Thanks. As a quick reminder again, if you'd like to ask a question over the phone, just press star one and one on your keypad. We'll move on now to the next question. That question is from Alicia Forry of Investec. Please go ahead.

Alicia Forry

analyst
#66

Hi, thanks for taking my question. For my first one, I was wondering if I could just follow up on what you said earlier about the Modern Oral rollout in the U.S. I appreciate that you don't want to discuss the product before its launch, but maybe you could say a little about which particular strengths you think will help you as you roll that product out. And then perhaps also any findings from the fact that you've been studying that product in that market for some time. What makes you confident that it's an attractive opportunity?

Stefan Bomhard

executive
#67

Right.

Alicia Forry

analyst
#68

That would be my first question. Then, if I may, a second one regarding the cannabis impairments—I'm just curious whether you could bring us up to date on your longer-term view of the cannabis opportunity. Thank you.

Stefan Bomhard

executive
#69

Absolutely. I'm glad to address that question. Regarding our move into modern oral nicotine — as you correctly point out, we've been examining this market for some time now. Meanwhile, we've reviewed every one of our competitors, and over the past 12 months we've conducted extensive consumer research to truly grasp what the marketplace lacks and what kind of proposition and opportunity we hold. So, as I mentioned, it's... I don't have any logical desire to get into specifics. We have indeed carried out substantial consumer testing across the US during the last 12 months, and we're fairly confident that what we're taking into the US market is a differentiated product. Building the right traction in the U.S. will require time, and our rollout will follow a phased approach, yet we feel very good that our offering stands apart in the U.S. marketplace. And we've done considerable testing — not only on the product but on the brand and every element as well. So I believe what's exciting about this is that it will demonstrate the skill set we've now built at Imperial, the marketing capabilities we've invested in over the last three years within the company.

Stefan Bomhard

executive
#70

So that's the situation we're in. Yeah. And regarding your second question, could you remind me what it was again?

Lukas Paravicini

executive
#71

Cannabis.

Stefan Bomhard

executive
#72

Yes, cannabis — sorry about that. On cannabis, the truth is our stance hasn't changed. Put simply, we always keep a watching brief, but the fact is, since we're companies that will only consider legal cannabis markets, nothing has really shifted in this market in practice. So we keep a watching brief, but right now, our strategy on cannabis is unchanged.

Alicia Forry

analyst
#73

I appreciate it.

Operator

operator
#74

Thanks. At this point, we have no additional questions coming in by phone. So I’ll turn things back over to Peter.

Peter Durman

executive
#75

Alright, thank you so much. Of course, should anybody wish to pose a question over the phone, we'll still be accepting those. Just press star and one, one, if you'd like to ask something. If not, we'll move ahead now and field questions from the room. We'll take one more question from Jon at the back.

Jon Lancaster

analyst
#76

Hi, just a couple of follow-ups, thanks. So just to confirm on the iSenzia launch, I wasn't entirely clear from your earlier answer — I mean, obviously these are non-tobacco and flavored, but are they permitted to be non-tobacco flavored, sort of, under the rules as they currently stand, or is it only a tobacco-flavored product? And then second, what guidance have you got, if any, when it comes to regulation and taxation for these products, given they're a non-tobacco product? That's the first question.

Stefan Bomhard

executive
#77

Of course. Jon, on iSenzia, let me reassure you directly: this product fully complies with every regulation currently in force in the markets where we're launching. Right. So, as you correctly point out, these are products that contain no tobacco. Right, nicotine is present, but tobacco is not. So they are definitely products that... We're bringing them to market to serve the needs of the consumer base we've established in our Heated Tobacco business. And the reality is that, just like any other product in NGP or in our core business, whenever regulation shifts, we'll adjust our offer accordingly. But I think what's... I want to return to this wider point. What I think should give you confidence is that, from having virtually no Heated Tobacco business in Europe roughly a year ago, aside from our two pilot markets, as regulation changes in Europe with the removal of tobacco flavors in the Heated Tobacco range, from day one, our consumers in the affected market have an offer from us, and for us, I think that's the exciting part. And we'll adapt this offer as regulation potentially changes going forward.

Jon Lancaster

analyst
#78

Apologies—just to pin this down, though: at this point, if it isn't a tobacco product, are they even taxable at all? And second, under the EU rules as they stand now—this is my own ignorance here—are they permitted to make flavors that aren't tobacco, assuming the product itself isn't tobacco, or—

Stefan Bomhard

executive
#79

Absolutely.

Jon Lancaster

analyst
#80

Does that still fall under the ban on non-tobacco, sort of?

Stefan Bomhard

executive
#81

Jon, I think the key point here is quite straightforward. It all comes down to the local rules in whichever country you're entering. So alongside our corporate affairs team and our legal team, any product that we at Imperial would bring to market will satisfy the full local standards in that market.

Jon Lancaster

analyst
#82

All right, and then second, regarding the lawsuit against the FDA, from where I sit, clearly, you received a favorable outcome in August. Have you made the decision to take that up to the Supreme Court or an En Banc Federal Court, or is that something still under consideration?

Stefan Bomhard

executive
#83

No, on this one I think it's a straightforward answer. The court decision has overturned the Marketing Denial Order. Yes, the FDA did not appeal that decision. So I think what's really exciting, as we've shared with you before, is that we felt very confident and very convinced that our case was a very strong one, and the court that ruled on it voted unanimously in our favor. So in principle, the Marketing Denial Order has been removed. That means the product now — it has always been in the market, as you know. It gives us the chance to drive distribution further into the marketplace. So that's what we're excited about, and we can now resubmit the documents into the process. Yeah. Which brings us back to exactly where the majority of the market is today, which is in the market where you can sell the product while your application is being considered. So we do not have to appeal to the Supreme Court or anything else. It has been decided by the lower courts.

Peter Durman

executive
#84

All right. Does anyone in the room have anything else? If there’s nothing more, I’ll return it to Stefan-

Stefan Bomhard

executive
#85

Yeah.

Peter Durman

executive
#86

So, to wrap things up.

Stefan Bomhard

executive
#87

Well, thanks for the question. For me, hopefully what we showed you today in the presentation and in the Q&A gives you a bit more evidence of the strong operational progress this company is making and the transformation journey we're on. And I think you can see, too, how that's translating into profit growth at the company. This was year three of the strategy. It was a step-up year for our strategy, and we've delivered on it. And I think what's exciting — and we may not have talked about it much today — is what you also see: the sustainability of the companies' cash flows, which will let us deliver and give us that ability to grow returns for our shareholders, something we're very excited about and very committed to. Thank you very much!

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Imperial Brands PLC transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Imperial Brands PLC earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Imperial Brands PLC or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.